Literature DB >> 8509767

Molecular pathology of Alzheimer's disease.

M N Rossor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8509767      PMCID： PMC489603          DOI： 10.1136/jnnp.56.6.583

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  34 in total

1.  Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases.

Authors:  J Collinge; M Poulter; M B Davis; M Baraitser; F Owen; T J Crow; A E Harding
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

2.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

3.  Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein.

Authors:  W E Van Nostrand; A H Schmaier; J S Farrow; D D Cunningham
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

4.  Genetic linkage studies in Alzheimer's disease families.

Authors:  M A Pericak-Vance; L H Yamaoka; C S Haynes; M C Speer; J L Haines; P C Gaskell; W Y Hung; C M Clark; A L Heyman; J A Trofatter
Journal:  Exp Neurol       Date:  1988-12       Impact factor: 5.330

5.  beta A4 amyloid protein deposition in brain after head trauma.

Authors:  G W Roberts; S M Gentleman; A Lynch; D I Graham
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

6.  The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.

Authors:  T Oltersdorf; L C Fritz; D B Schenk; I Lieberburg; K L Johnson-Wood; E C Beattie; P J Ward; R W Blacher; H F Dovey; S Sinha
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

7.  Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells.

Authors:  J P Anderson; F S Esch; P S Keim; K Sambamurti; I Lieberburg; N K Robakis
Journal:  Neurosci Lett       Date:  1991-07-08       Impact factor: 3.046

8.  Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells.

Authors:  K Abe; P H St George-Hyslop; R E Tanzi; K Kogure
Journal:  Neurosci Lett       Date:  1991-04-29       Impact factor: 3.046

9.  Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex.

Authors:  K Abe; R E Tanzi; K Kogure
Journal:  Neurosci Lett       Date:  1991-04-29       Impact factor: 3.046

10.  Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds.

Authors:  T D Bird; S M Sumi; E J Nemens; D Nochlin; G Schellenberg; T H Lampe; A Sadovnick; H Chui; G W Miner; J Tinklenberg
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 11.274
View more
  8 in total

Review 1.  Alzheimer's disease.

Authors:  M Rossor
Journal:  BMJ       Date:  1993-09-25

2.  The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy.

Authors:  S K Newman; E K Warrington; A M Kennedy; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

Review 3.  Potential role of muscarinic agonists in Alzheimer's disease.

Authors:  E E Avery; L D Baker; S Asthana
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

4.  Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene.

Authors:  R J Harvey; D Ellison; J Hardy; M Hutton; P K Roques; J Collinge; N C Fox; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

5.  Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism.

Authors:  M Lehtovirta; J Kuikka; S Helisalmi; P Hartikainen; A Mannermaa; M Ryynänen; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

Review 6.  Biological Effects of Tetrahydroxystilbene Glucoside: An Active Component of a Rhizome Extracted from Polygonum multiflorum.

Authors:  Lingling Zhang; Jianzong Chen
Journal:  Oxid Med Cell Longev       Date:  2018-11-04       Impact factor: 6.543

7.  Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer's Disease Mouse Model.

Authors:  Wan Nurzulaikha Wan Nasri; Suzana Makpol; Musalmah Mazlan; Ikuo Tooyama; Wan Zurinah Wan Ngah; Hanafi Ahmad Damanhuri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics.

Authors:  Xuan Cheng; Lu Zhang; Ya-Jun Lian
Journal:  Biomed Res Int       Date:  2015-11-19       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.